Lakewood-Amedex Biotherapeutics Redeems All Remaining Preferred Shares for $1.27 Million
Bitget2026/11/05 13:08- Lakewood-Amedex Biotherapeutics today completed redemption of all 127,097 remaining Series C Convertible Preferred Stock shares for $1.27 million.
- Cash on hand funded the redemption under a November 2, 2026, agreement with Shakawe Capital.
- No preferred stock or indebtedness for borrowed money remains outstanding.
- The redemption eliminates potential dilution from Series C Preferred Stock conversions and removes associated financing restrictions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Crypto prices
More
